PMV

Minze Health is a Belgian healthech startup that develops digital health solutions for the treatment of urinary tract problems. The company's digital health and remote patient monitoring (RPM) solutions are being used by hospitals, urology practices, and pelvic floor rehabilitation centers worldwide. Minze Health was established in 2015 and is headquartered in Antwerp, Belgium.

Gorilla focuses on transforming the energy and utility industry through innovative energy data applications. The company addresses longstanding data challenges that hinder innovation by offering a robust architectural data foundation tailored specifically for energy companies. Its platform features a flexible data model and a stable environment, which includes reusable algorithms that facilitate a quicker digital transformation process. By automating data collection and providing tools for pricing, forecasting, and reporting, Gorilla empowers energy retailers to leverage data-driven technology, thereby enhancing their sales while mitigating risks. With offices in Antwerp, London, Austin, and Melbourne, Gorilla is positioned to support energy companies in maximizing their return on investment from data.

MICLEDI Microdisplays BV specializes in designing and manufacturing micro light-emitting diode (microLED) display chips tailored for augmented reality (AR) glasses. Based in Leuven, Belgium, the company operates as a fabless developer, focusing on advanced technology that integrates III/V materials processing, 3D integration, and 300mm silicon-based processing. MICLEDI's proprietary application-specific integrated circuit (ASIC) enables the production of compact, monolithic AR displays that deliver high image quality and enhanced power efficiency. By providing microLED display modules on wafers, MICLEDI serves the semiconductor industry, contributing to the advancement of AR technology.

IVEX is a start-up originating from the University of Leuven, specializing in the development of tools and software designed for the testing and validation of advanced driver assistance systems (ADAS) and autonomous vehicles. The company comprises a diverse team and has established partnerships with global firms, notably Siemens, to enhance its growth in the high-tech sector. IVEX offers a cloud-based suite of testing and validation tools alongside an onboard real-time safety checker, which can function independently or in conjunction with other systems. Its solutions streamline the analysis of extensive driving data, enabling engineers to efficiently identify and categorize driving scenarios, create digital representations for simulation, and assess safety performance while minimizing computational resource usage. By focusing on safety and efficiency, IVEX aims to support the industry's need for reliable and effective validation of automated driving technologies.

Gorilla focuses on transforming the energy and utility industry through innovative energy data applications. The company addresses longstanding data challenges that hinder innovation by offering a robust architectural data foundation tailored specifically for energy companies. Its platform features a flexible data model and a stable environment, which includes reusable algorithms that facilitate a quicker digital transformation process. By automating data collection and providing tools for pricing, forecasting, and reporting, Gorilla empowers energy retailers to leverage data-driven technology, thereby enhancing their sales while mitigating risks. With offices in Antwerp, London, Austin, and Melbourne, Gorilla is positioned to support energy companies in maximizing their return on investment from data.

Minze Health is a Belgian healthech startup that develops digital health solutions for the treatment of urinary tract problems. The company's digital health and remote patient monitoring (RPM) solutions are being used by hospitals, urology practices, and pelvic floor rehabilitation centers worldwide. Minze Health was established in 2015 and is headquartered in Antwerp, Belgium.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

CHILI Publish is a Belgium-based company that specializes in online editing software designed to transform original designs into Smart Templates. Founded in 2010 and headquartered in Erembodegem, the company aims to simplify and automate graphic production for businesses across various industries, including marketing, retail, cosmetics, and food and beverage. Its innovative software provides a comprehensive suite of templates and customizable features that facilitate the creation of on-brand visual communications for both print and packaging. By integrating with a wide range of third-party partners, CHILI Publish enables marketers, brands, and printers to utilize a self-service platform, enhancing efficiency in producing graphics for diverse purposes.

Sweepatic operates a cloud-based platform focused on External Attack Surface Management, aimed at enhancing cybersecurity for organizations. The platform continuously maps, monitors, and manages all internet-connected assets and associated risks, providing 24/7 observations and high-impact notifications through an intuitive dashboard. By leveraging this technology, Sweepatic helps organizations structure and reduce their external attack surface, thereby minimizing their vulnerability to cyber threats. Headquartered in Belgium, Sweepatic is committed to making its customers more cyber resilient by delivering actionable insights and easy-to-remediate findings.

reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein-misfolding disorders. The company is advancing several investigational compounds, including ReS19-T for Alzheimer’s and ReS39 for diabetes, as well as ReS3-T, which targets neuronal hyperactivity associated with Alzheimer’s and epilepsy. Additionally, reMYND operates a phenotypic screening platform aimed at discovering small molecule treatments that mitigate the toxicity of misfolded proteins such as Tau and Synuclein. The company also functions as a contract research organization (CRO), providing services that assess the in-vivo characteristics and effects of experimental therapies using proprietary mouse models. This CRO capability has enabled reMYND to support various pharmaceutical clients, including major companies in the United States, Europe, and Japan, by delivering critical proof-of-concept data for drugs in clinical development. Established in 2002, reMYND is committed to addressing the challenges posed by protein misfolding diseases through innovative research and development.

SettleMint offers a user-friendly platform that enables web2 engineers to build, deploy, and integrate applications on web3 infrastructure. The company provides a comprehensive suite of tools covering the entire web3 application development lifecycle. This includes node hosting as a service, customizable smart contract templates for over 50 use cases, and efficient on-chain data querying through Graph QL integration. Additionally, SettleMint supports decentralized data storage with IPFS node deployment, alongside centralized storage options. The platform features a fully automated and customizable user interface builder, ensuring scalability with easy resource management. With SOC2 certification and enterprise-grade capabilities, SettleMint simplifies the complexities of web3 development for businesses across Europe, the Middle East, Africa, India, and Asia-Pacific, with offices in key cities such as Belgium, Dubai, Delhi, Singapore, and Tokyo.

CHILI Publish is a Belgium-based company that specializes in online editing software designed to transform original designs into Smart Templates. Founded in 2010 and headquartered in Erembodegem, the company aims to simplify and automate graphic production for businesses across various industries, including marketing, retail, cosmetics, and food and beverage. Its innovative software provides a comprehensive suite of templates and customizable features that facilitate the creation of on-brand visual communications for both print and packaging. By integrating with a wide range of third-party partners, CHILI Publish enables marketers, brands, and printers to utilize a self-service platform, enhancing efficiency in producing graphics for diverse purposes.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

QustomDot is a company based in Ghent, Belgium, specializing in the development and manufacturing of on-chip grade and cadmium-free quantum dots. These tiny semiconductor nanoparticles are designed to transform ultraviolet or blue light into pure colors, enhancing the image quality of various display technologies. QustomDot's products are applicable in LED/LCD televisions, smartphones, smartwatches, virtual and augmented reality goggles, and LED lighting solutions. The company not only produces quantum dots but also assists customers in integrating these advanced materials into their products, helping to improve color gamut and energy efficiency. Founded in 2020, QustomDot is focused on innovation in the field of advanced materials.

IVEX is a start-up originating from the University of Leuven, specializing in the development of tools and software designed for the testing and validation of advanced driver assistance systems (ADAS) and autonomous vehicles. The company comprises a diverse team and has established partnerships with global firms, notably Siemens, to enhance its growth in the high-tech sector. IVEX offers a cloud-based suite of testing and validation tools alongside an onboard real-time safety checker, which can function independently or in conjunction with other systems. Its solutions streamline the analysis of extensive driving data, enabling engineers to efficiently identify and categorize driving scenarios, create digital representations for simulation, and assess safety performance while minimizing computational resource usage. By focusing on safety and efficiency, IVEX aims to support the industry's need for reliable and effective validation of automated driving technologies.

MICLEDI Microdisplays BV specializes in designing and manufacturing micro light-emitting diode (microLED) display chips tailored for augmented reality (AR) glasses. Based in Leuven, Belgium, the company operates as a fabless developer, focusing on advanced technology that integrates III/V materials processing, 3D integration, and 300mm silicon-based processing. MICLEDI's proprietary application-specific integrated circuit (ASIC) enables the production of compact, monolithic AR displays that deliver high image quality and enhanced power efficiency. By providing microLED display modules on wafers, MICLEDI serves the semiconductor industry, contributing to the advancement of AR technology.

Augustine Therapeutics N.V., founded in 2019 and based in Gent, Belgium, focuses on developing innovative medicines for patients suffering from Charcot-Marie-Tooth disease and other neuromuscular disorders. The company is engaged in two drug discovery programs aimed at identifying new generations of selective HDAC6 inhibitors, which are designed to address axonopathies, including Charcot-Marie-Tooth disease. These novel compounds are intended to protect against nerve degeneration and facilitate the repair of peripheral myelin and axons. By advancing these therapeutic drugs, Augustine Therapeutics aims to enhance the quality of life for patients affected by these debilitating conditions.

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Unifly is a drone traffic management software company focused on the safe integration of drones into the global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers and engineers to manage the increasing presence of unmanned aircraft. Unifly's award-winning platform allows drone operators to check the legal status of their flights while enabling authorities to monitor and manage drone traffic effectively. The platform is currently utilized by national authorities in countries such as Germany, Denmark, Austria, and Belgium, and is also active in the United States and Africa. Unifly has established itself as a leader in unmanned traffic management technology, working collaboratively with various stakeholders, including research entities and businesses, to enhance airspace safety and efficiency. By providing essential tools for drone operators and regulators, Unifly aims to facilitate the seamless integration of drones into daily life while prioritizing safety and transparency.

Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.

SupplyStack, based in Antwerp, Belgium, provides a real-time visibility solution for monitoring transport orders, enabling effective collaboration and automating various logistical processes. The company offers a comprehensive platform that integrates a visibility solution with a transport management system, allowing users to track and manage logistics efficiently. SupplyStack serves a diverse range of industries, including automotive, industrial manufacturing, FMCG, chemicals, wholesale and distribution, pharmaceuticals, and food and beverage. Its software facilitates real-time monitoring and planning of transportation flows, helping logistics service providers and shippers enhance operational efficiency and reduce costs while improving overall service quality.

reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein-misfolding disorders. The company is advancing several investigational compounds, including ReS19-T for Alzheimer’s and ReS39 for diabetes, as well as ReS3-T, which targets neuronal hyperactivity associated with Alzheimer’s and epilepsy. Additionally, reMYND operates a phenotypic screening platform aimed at discovering small molecule treatments that mitigate the toxicity of misfolded proteins such as Tau and Synuclein. The company also functions as a contract research organization (CRO), providing services that assess the in-vivo characteristics and effects of experimental therapies using proprietary mouse models. This CRO capability has enabled reMYND to support various pharmaceutical clients, including major companies in the United States, Europe, and Japan, by delivering critical proof-of-concept data for drugs in clinical development. Established in 2002, reMYND is committed to addressing the challenges posed by protein misfolding diseases through innovative research and development.

Teamleader, based in Belgium, is a software company that provides a comprehensive platform for project management and invoicing, aimed at helping entrepreneurs streamline their business operations. With over 7,000 paying customers, the company has experienced significant growth and is poised for further expansion. Teamleader's user-friendly interface, competitive pricing, and extensive integrations make it an appealing choice for businesses looking to manage their sales, project management, calendar, time tracking, invoicing, and ticketing in one place. By simplifying these essential functions, Teamleader enables clients to save time and focus on increasing their revenue.

ONTOFORCE is a company that specializes in enhancing research and drug development within the life sciences sector by enabling organizations to uncover valuable insights from disparate data sources. Its primary product, DISQOVER, is a knowledge discovery platform built on semantic technology and ontology-based structures. This platform integrates an organization’s internal data with licensed and public data, facilitating efficient exploration and analysis. DISQOVER is user-friendly and customizable, catering to a diverse audience that includes scientific researchers, bioinformaticians, and data scientists. With over 10,000 global users, ONTOFORCE's solutions are adopted by many prominent pharmaceutical and biotechnology firms. The company is headquartered in Ghent, Belgium, and maintains a secondary office in Cambridge, Massachusetts.

Aelin Therapeutics, a privately held Belgian biotherapeutics company.Aelin Therapeutics is founded by VIB and its partner universities KU Leuven, VUB and UGent, based on the groundbreaking work of renowned structural biologists Prof Joost Schymkowitz and Prof Frederic Rousseau. The company is based on a very comprehensive preclinical Proof of Concept data package illustrating different applications of the technology such as in bacteria and cancer cells, but also in fungi, viruses and plant cells, with publications in high impact journals including Science. The Pept-in technology allows for the rational design of novel biotherapeutics and differentiates itself from any other therapeutic modality through its unique mode of action, its designability and intracellular target space out of reach for typical small molecule or antibody approaches.

Laminaria, founded in 2011 and based in Ostend, Belgium, specializes in manufacturing wave energy converter equipment. The company is at the forefront of developing technology designed to harness renewable wave energy, using a system that converts tilting and translating motions into power through mooring ropes connected to generators. Laminaria leads the LAMWEC project, a consortium of ocean energy experts that includes organizations such as EMEC, Innosea, Ghent University, and TTI Testing. Through its innovative technology, Laminaria aims to significantly impact the renewable energy landscape by advancing the effectiveness and efficiency of wave energy conversion.

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Newtec is specialized in designing, developing, and manufacturing equipment and technologies for satellite communications. Tomorrow’s realizations are built on today’s innovation, on our drive to create new possibilities in satellite communications. For over 30 years, Newtec’s team of dedicated specialists set the standards: designing, developing and manufacturing the most efficient, most scalable and most economical technology in the industry. New challenges and new customer needs offer opportunities to explore new boundaries. This empowers us to work even harder, helping our customers to perform their best so that, together, we can make the world a safer, better informed and more connected place. Established in 1985, and headquartered in Belgium, Newtec has regional offices as well as additional R&D centers located in Stamford, Conn. (U.S.), Singapore (Singapore), Beijing (China), Dubai (UAE), São Paulo (Brazil), Berlin (Germany), and France.

VIRTEO NV, founded in 2013 and based in Mechelen, Belgium, operates a SaaS platform designed for the recovery of unpaid invoices. The platform addresses both internal dunning and external debt collection processes, catering to a diverse clientele that includes corporations, small and medium-sized enterprises, public institutions, court bailiffs, and lawyers. By facilitating direct collaboration between credit managers and external partners such as lawyers and recovery agencies, VIRTEO enhances efficiency, transparency, and compliance in debt collection. The company aims to reconcile the often negative perception of the debt collection industry with socially responsible practices, enabling creditors to recover debts while adhering to ethical standards. Through its platform, VIRTEO empowers customers to monitor, control, and enforce their corporate social responsibility policies, ultimately improving recovery outcomes and reducing costs.

ONTOFORCE is a company that specializes in enhancing research and drug development within the life sciences sector by enabling organizations to uncover valuable insights from disparate data sources. Its primary product, DISQOVER, is a knowledge discovery platform built on semantic technology and ontology-based structures. This platform integrates an organization’s internal data with licensed and public data, facilitating efficient exploration and analysis. DISQOVER is user-friendly and customizable, catering to a diverse audience that includes scientific researchers, bioinformaticians, and data scientists. With over 10,000 global users, ONTOFORCE's solutions are adopted by many prominent pharmaceutical and biotechnology firms. The company is headquartered in Ghent, Belgium, and maintains a secondary office in Cambridge, Massachusetts.

Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands. Avantium's proprietary high-throughput technology enables a faster and more cost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development. Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields: new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent. Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business. Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

neoScores is a pioneer in offering digital music scores. It gives musicians the opportunity to simply and securely purchase scores or to use and to share notes with fellow musicians, anywhere they are. Gustaf is an OS and device independent web platform that allows the distribution of digital sheet music. High in quality, easy and flexible, beautiful and stylish, Gustaf allows to use scores via smartphone, tablet or computer through any operating system. That is how neoScores® wants to change the way sheet music is used by musicians. neoScores® was founded in July 2013 by Bart Van der Roost, Bob Hamblok and Jonas Coomans, three professional musicians with a passion for new media.

Trod Medical S.A. is a medical device manufacturer founded in 2006, with headquarters in Leuven, Belgium, and the Tampa Bay area, USA. The company specializes in innovative ablation technologies, particularly in developing radiofrequency (RF) ablation devices. One of its key products, the EncageTM, is a percutaneous RF device designed to precisely ablate soft tissues, minimizing collateral damage during procedures. This technology is particularly significant in the treatment of prostate cancer, a prevalent condition with approximately 240,000 new cases diagnosed annually in the United States. Traditional treatments often lead to severe side effects, such as erectile dysfunction and urinary incontinence, highlighting the importance of Trod Medical's advancements. The company's devices enable healthcare providers to perform endoscopic surgeries with predictable ablation volumes and reduced tissue damage, aiming to improve patient outcomes in a critical area of medical care.

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Argenx is a global immunology company based in the Netherlands, dedicated to enhancing the lives of individuals affected by severe autoimmune diseases and cancer. The company employs advanced antibody engineering technology to develop treatments for rare autoimmune conditions. Its notable product, Vyvgart (efgartigimod), received initial approval in the United States in December 2021 for the treatment of generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022. Through its innovative approaches, Argenx aims to address unmet medical needs in the field of immunology.

Caliopa NV develops and markets silicon photonics based optical transceivers for the data and telecommunications markets. The company was incorporated in 2010 and is based in Zwijnaarde, Belgium.

iNEWiT, an engineering company, engages in identifying, designing, and creating applications and devices for the mobile market. It provides mobile video communication applications; wireless communication technologies, ranging from GPRS/EDGE, over 3G, HSDPA/HSUPA to WiFi, and WiMAX and satellite networks; and plug and play products for the business-to-consumer markets. The company was founded in 2005 and is based in Mechelen, Belgium

Quick Sensor N.V. offers seat control and detection system that provides overview of the audience behavior with the use of sensors embedded in movie theatre seating. Its system enables seat detection, as well as gathers and stores the seating information for retrieval and processing. Quick Sensor N.V. was founded in 2004 and is headquartered in Izegem, Belgium.

iNEWiT, an engineering company, engages in identifying, designing, and creating applications and devices for the mobile market. It provides mobile video communication applications; wireless communication technologies, ranging from GPRS/EDGE, over 3G, HSDPA/HSUPA to WiFi, and WiMAX and satellite networks; and plug and play products for the business-to-consumer markets. The company was founded in 2005 and is based in Mechelen, Belgium